luteinising hormone-releasing hormone agonist ( buserelin ) therapy administered for a period of 6 months in 4 patients with longstanding , severe , danazol-resistant endometriosis , was found to be effective in reducing all complaints related to endometriosis .
C0010961
danazol
C0014175
endometriosis